Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-11-000025
Filing Date
2011-01-13
Accepted
2011-01-13 17:21:04
Documents
8
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ohr-10k_0112.htm 10-K 1306955
2 REPLACEMENT WARRANT ex-10_15.htm EX-10.15 105935
3 CODE OF ETHICS ex-14.htm EX-14 35563
4 CERTIFICATION ex-31_1.htm EX-31.1 16404
5 CERTIFICATION ex-31_2.htm EX-31.2 16918
6 CERTIFICATION ex-32_1.htm EX-32.1 6958
7 CERTIFICATION ex-32_2.htm EX-32.2 6486
8 ohr-10k_01124.jpg GRAPHIC 37287
  Complete submission text file 0001387131-11-000025.txt   1548378
Mailing Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106
Business Address 1245 BRICKYARD RD #590 SALT LAKE CITY, UT 84106 347-753-4389
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

EIN.: 133709558 | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 333-88480 | Film No.: 11528234
SIC: 3669 Communications Equipment, NEC